Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Working Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.423.704.532.563.89

What is the latest Working Capital/Sales ratio of MANKIND PHARMA ?

The latest Working Capital/Sales ratio of MANKIND PHARMA is 2.42 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.42
Mar20233.70
Mar20224.53
Mar20212.56
Mar20203.89

How is Working Capital/Sales of MANKIND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 2.42
-34.59
Mar2023 3.7
-18.32
Mar2022 4.53
76.95
Mar2021 2.56
-34.19
Mar2020 3.89 -

Other Financial Ratios of MANKIND PHARMA


Compare Working Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,240.6 Cr -2.1% -0.6% 33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.1%

-0.6%

33.1%

SENSEX

1.8%

-2.5%

19.9%


You may also like the below Video Courses